DrugPrices

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

Supreme Court Weighs In on Medicare Drug‑Price Negotiations

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

Senator Warren Slams Trump's 'Mathematically Impossible' Drug Price Claim

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

America's Medicine Cabinet: Unpacking the Tariffs Debate and Our Global Drug Reliance

The Cost Conundrum: Unpacking Massachusetts' Sky-High Healthcare Bills

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Global Turmoil Squeezes India's Pharma: Drugmakers Plead for Input Price Caps

The Uncharted Alliance: Klotho Neurosciences Forges Unexpected Path with Greenland Mining Giant

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

An Unexpected Turn: America's Drug Price Paradox

A Real Plan to Tackle Soaring Drug Costs

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

The Cost of Cures: Unpacking America's Enduring Drug Price Predicament

Unpacking the Ambition: Trump's Most-Favored-Nation Drug Pricing Push

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

A New Prescription for Prosperity: US & UK Seal Zero-Tariff Pharma Deal

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A New Era for Drug Prices: How Medicare's Negotiation Power is Reshaping Healthcare

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

A Grand Bargain for Health? The Looming Question of Obesity Drugs and Who Pays.

The GLP-1 Gambit: Pharma Giants, Trump, and the High Stakes of Drug Prices

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Ghost in the Machine: How Trump's Drug Price Transparency Memo Almost Changed Everything—But Didn't

The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets